Korea, Democratic People's Republic of (the)

in page functions
[French]
Total population (2016) 25,281,199
Birth cohort (2016) 361,216
Surviving Infants (surviving to 1 year per year, 2016) 354,014
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 20/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 25/1000
Co-financing status (2016) Initial self-financing
No. of districts/territories (2014) 210

Gavi support for DPR Korea

Type of support

Approvals

2001-2020 (US$)
(31 Mar 2016)

Commitments

2001-2020 (US$)
(31 Mar 2016)

Disbursements

2000-2016 (US$)
(31 Mar 2016)

% Disbursed

(31 Mar 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Health system strengthening (HSS 1) $4,360,000 $4,360,000 $4,360,000 100%
Health system strengthening (HSS 2) $11,130,716 $26,039,481 $6,155,859 55%
HepB mono (NVS) $2,043,505 $2,043,505 $2,043,505 100%
Immunisation services support (ISS) $2,222,971 $2,222,971 $2,222,971 100%
Injection safety support (INS) $743,726 $743,726 $743,726 100%
IPV (NVS) $1,772,460 $2,478,460 $1,131,396 64%
Measles (NVS) $938,383 $938,383 $982,252 105%
Penta (NVS) $11,241,338 $11,241,338 $11,887,658 106%
Tetra DTP-HepB (NVS) $6,552,614 $6,552,614 $6,552,614 100%
Vaccine Introduction Grant (VIG) $615,275 $615,275 $615,275 100%
Total $41,620,988 $57,235,753 $36,695,256

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

DPR Korea DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 93%
M:F sex ratio at birth (2016) 1.05
Household survey: Last DTP3 survey (2007) 92%
% districts achieving > 80% DTP3 coverage (2014) 100%
% districts achieving < 50% DTP3 coverage (2014) 0%
MCV WHO/UNICEF estimates (2014) 99%

Breakdown of support

Non-vaccine support Vaccine support
38% 62%
$14,097,829 $22,597,423

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to DPR Korea

18 September 2014

Nepal IPV

Nepal becomes first country to introduce IPV with Gavi support

Nepal is one of 25 countries who have received approval to begin using IPV with Gavi support. Afghanistan and Pakistan are also planning to introduce IPV by end of next year.

03 December 2012

DPR Korea introduces pentavalent vaccine

In July 2012, the Democratic People's Republic of Korea (DPRK) introduced pentavalent vaccine with support from the GAVI Alliance. Children in DPR Korea will benefit from protection against Haemophilus influenzae type b (Hib) disease in addition to continuing protection from four other childhood killers as the country introduces the five-in-one pentavalent vaccine into its routine immunisation programme.

28 November 2012

UNICEF_2009_Bura_Indonesia copyF
close icon

modal window here